On September 26, 2023, Ruibo (Hangzhou) Pharmaceutical Technology Co., Ltd. closed the transaction. The company's registered capital is CNY 91,970,802.92.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.22 CNY | -1.55% | -4.40% | -37.13% |
May. 23 | Jiuzhou Pharmaceutical Plans CRO in Germany | MT |
Apr. 24 | Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.13% | 1.89B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Ruibo Pharmaceutical Technology Co., Ltd. announced that it has received CNY 20 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd